Baseline patient characteristics
| Characteristics . | No. . |
|---|---|
| No. of patients | 63 |
| Sex, no. M/F | 56/7 |
| Median age, y (range) | 40 (20-57) |
| HIV transmission, no. | |
| Homosexual | 38 |
| Heterosexual | 13 |
| IV drug user | 10 |
| Unknown | 2 |
| CD4 cell count, × 106/L | |
| Median | 239 |
| Range | 16-1188 |
| No. less than 100 | 13/63 |
| CD8 cell count, × 106/L | |
| Median | 1074 |
| Range | 40-6356 |
| Nadir CD4 cell count, × 106/L | |
| Median | 205 |
| Range | 7-780 |
| Plasma HIV-RNA, copies/mL | |
| No. of patients with HIV-RNA less than 50 | 16/63 |
| In patients with HIV-RNA more than 50 | |
| Median | 63950 |
| Range | 599-3281900 |
| Antiretroviral therapy | 33 (HAART in 31) |
| Characteristics . | No. . |
|---|---|
| No. of patients | 63 |
| Sex, no. M/F | 56/7 |
| Median age, y (range) | 40 (20-57) |
| HIV transmission, no. | |
| Homosexual | 38 |
| Heterosexual | 13 |
| IV drug user | 10 |
| Unknown | 2 |
| CD4 cell count, × 106/L | |
| Median | 239 |
| Range | 16-1188 |
| No. less than 100 | 13/63 |
| CD8 cell count, × 106/L | |
| Median | 1074 |
| Range | 40-6356 |
| Nadir CD4 cell count, × 106/L | |
| Median | 205 |
| Range | 7-780 |
| Plasma HIV-RNA, copies/mL | |
| No. of patients with HIV-RNA less than 50 | 16/63 |
| In patients with HIV-RNA more than 50 | |
| Median | 63950 |
| Range | 599-3281900 |
| Antiretroviral therapy | 33 (HAART in 31) |